bacterial RNA polymerase beta subunit — Drug Target
All drugs that target bacterial RNA polymerase beta subunit — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Bacterial RNA polymerase inhibitor
Phase 3 pipeline (1)
- Rifampin containing regimen · Nantes University Hospital · Bacterial RNA polymerase inhibitor · Infectious Diseases
Rifampin inhibits bacterial RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.